Transplant glomerulopathy

American Journal of Transplantation

Volumn 8, Issue 3, 2008, Pages 492-496

  Cosio, F G ^a   Gloor, J M ^a   Sethi, S ^a   Stegall, M D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anti HLA antibodies; C4d; Capillaries; Endothelial cells

Indexed keywords

COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ALLOGRAFT; BASEMENT MEMBRANE; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GLOMERULUS BASEMENT MEMBRANE; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; TRANSPLANT GLOMERULOPATHY;

ANTIBODIES; DIAGNOSIS, DIFFERENTIAL; GLOMERULONEPHRITIS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; TISSUE DONORS;

EID: 39649115166     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02104.x     Document Type: Short Survey

References (25)

1. Hood B, Olander R, Nagy Z, Bergentz SE. Glomerulopathy in the transplanted kidney. Scand J Urol Nephrol 1970 4 : 135 142.
2. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007 18 : 1046 1056.
3. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
4. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005 5 : 2464 2472.
5. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007 9 : 2124 2132.
6. Yamamoto I, Horita S, Takahashi T et al. Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy. Am J Transplant 2007 7 : 1954 1960.
7. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007 7 : 1743 1752.
8. Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 1985 27 : 799 806.
9. Monga G, Mazzucco G, Novara R, Reale L. Intertubular capillary changes in kidney allografts: An ultrastructural study in patients with transplant glomerulopathy. Ultrastruct Pathol 1990 14 : 201 209.
10. de Heer E, Davidoff A, van der Wal A, van Geest M, Paul LC Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 1994 70 : 494 502.
11. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574 582.
12. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
13. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993 43 : 1333 1338.
14. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.
15. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992 53 : 550 555.
16. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation 1996 61 : 1586 1592.
17. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
18. Liptak P, Kemeny E, Morvay Z et al. Peritubular capillary damage in acute humoral rejection: An ultrastructural study on human renal allografts. Am J Transplant 2005 5 : 2870 2876.
19. Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
20. Campos EF, Tedesco-Silva H, Machado PG, Franco M, Medina-Pestana JO, Gerbase-DeLima M. Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006 6 : 2316 2320.
21. Langan LL, Park LP, Hughes TL et al. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 2007 7 : 847 856.
22. Mao Q, Terasaki PI, Cai J et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2007 7 : 864 871.
23. Cai J, Terasaki PI, Mao Q et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006 6 : 2947 2954.
24. Muczynski KA, Ekle DM, Coder DM, Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: Characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003 14 : 1336 1348.
25. Joosten SA, Sijpkens YW, van Ham V et al. Antibody response against the GBM protein Agrin in patients with transplant glomerulopathy. Am J Transplant 2005 5 : 383 393.